Clinical Trial Update: Post Market Study Using The Elite IQ Device [NA]

View source ↗

Summary

A post-market study assessing Cynosure's Elite IQ device for hair removal and related skin conditions has completed, with results posted in June 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Vascular Lesion
• Pigmented Lesions
• Pseudo Folliculitis Barbae

Drugs mentioned

• Elite IQ Device

Snippet

Sponsor: Cynosure, Inc. | Conditions: Hair Removal, Pseudo Folliculitis Barbae | NA | Status: COMPLETED | Results posted: 2023-06-15